Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidine)
D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010113:Oxyphenbutazone / Q000009:adverse effects*; D010328:Patch Tests; D010653:Phenylbutazone / Q000009:adverse effects*
D010653:Phenylbutazone; D010113:Oxyphenbutazone